Quick Takeaways
- Carl C. Icahn filed SCHEDULE 13D/A for ENZON PHARMACEUTICALS INC Common Stock, No par value (ENZN).
- Disclosed ownership: 49%.
- Date of event: 19 Dec 2024.
Carl C. Icahn - 19 Dec 2024 SCHEDULE 13D/A Report for ENZON PHARMACEUTICALS INC Common Stock, No par value (ENZN)
- Filing Manager
- Carl C. Icahn
- Reporting Manager
- CARL C ICAHN
- Symbol
- ENZN
- Shares outstanding
- 74,190,609 shares
- Disclosed Ownership
- 36,056,636 shares
- Ownership
- 49%
- Form type
- SCHEDULE 13D/A
- Filing time
- 19 Dec 2024, 16:30:40 UTC
- Date of event
- 19 Dec 2024
- Next filing
- 23 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Carl C. Icahn disclosed 49% ownership in ENZON PHARMACEUTICALS INC Common Stock, No par value (ENZN) on 19 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 19 Dec 2024, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (10)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| CARL C ICAHN | 49% | 36,056,636 | 0 | 36,056,636 | /s/ CARL C. ICAHN | CARL C. ICAHN | 0000921669 |
| ICAHN PARTNERS MASTER FUND LP | 20% | 14,923,911 | 14,923,911 | 0 | /s/ Jesse Lynn | Jesse Lynn / Chief Operating Officer | 0001322827 |
| Icahn Offshore LP | 20% | 14,923,911 | 0 | 14,923,911 | /s/ Jesse Lynn | Jesse Lynn / Chief Operating Officer | 0001322825 |
| Icahn Partners LP | 28% | 21,132,725 | 21,132,725 | 0 | /s/ Jesse Lynn | Jesse Lynn / Chief Operating Officer | 0001313666 |
| Icahn Onshore LP | 28% | 21,132,725 | 0 | 21,132,725 | /s/ Jesse Lynn | Jesse Lynn / Chief Operating Officer | 0001322826 |
| Icahn Capital LP | 49% | 36,056,636 | 0 | 36,056,636 | /s/ Jesse Lynn | Jesse Lynn / Chief Operating Officer | 0001412093 |
| IPH GP LLC | 49% | 36,056,636 | 0 | 36,056,636 | /s/ Ted Papapostolou | Ted Papapostolou / Chief Financial Officer | 0001412091 |
| ICAHN ENTERPRISES HOLDINGS L.P. | 49% | 36,056,636 | 0 | 36,056,636 | /s/ Ted Papapostolou | Ted Papapostolou / Chief Financial Officer | 0001034563 |
| ICAHN ENTERPRISES G.P. INC. | 49% | 36,056,636 | 0 | 36,056,636 | /s/ Ted Papapostolou | Ted Papapostolou / Chief Financial Officer | 0001257324 |
| BECKTON CORP | 49% | 36,056,636 | 0 | 36,056,636 | /s/ Ted Papapostolou | Ted Papapostolou / Vice President | 0001080113 |